{
  "docId": "019dd923-622c-750b-8b98-08d95731b035",
  "docSlug": "4dea9707af58",
  "documentTitle": "AtriCure, Inc. (ATRC)",
  "authorId": "53_Kerrisdale_Capital",
  "authorName": "Kerrisdale Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2020-09-01 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 31,
  "pageCount": 34,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "closing_ask",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "This is a text-heavy research note conclusion page.",
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b98-08d95731b035/31",
  "deckHref": "/decks/019dd923-622c-750b-8b98-08d95731b035",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b98-08d95731b035.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b98-08d95731b035#slide-31",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The implication for AtriCure is that its best hope for growth is already dead, and it hasn't even been approved yet.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-0396-73da-b906-da52776af8de",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.74,
        "x": 0.128,
        "y": 0.338
      },
      "kind": "paragraph",
      "text": "The performance of AtriCure's stock price over the past six months... indicates that investors see the Convergent procedures as a powerful growth lever... In our view, nothing could be further from reality.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c58e916-540c-48bc-8ccb-4c377af035e9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.74,
        "x": 0.128,
        "y": 0.093
      },
      "kind": "paragraph",
      "text": "AF (and other arrhythmias) emanating from other locations around the heart that have yet to be identified. As that happens, the superiority of catheter ablation over the blunt instrument of a surgical procedure will be further enhanced.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "431ce64b-3eaa-4c35-92ea-cd6d636f34df",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.74,
        "x": 0.128,
        "y": 0.508
      },
      "kind": "paragraph",
      "text": "Even the well-designed catheter ablation trials conducted 8-10 years ago... suggest that the safest way to treat these patients is with a single catheter ablation procedure... The implication for AtriCure is that its best hope for growth is already dead.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d3c33ca-395a-40b2-a79e-d8546bdc614f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.74,
        "x": 0.128,
        "y": 0.708
      },
      "kind": "paragraph",
      "text": "If that weren't enough, new catheter technologies such as pulsed field ablation... will soon reach levels that will make the procedure a reasonable option even for patients who are set to undergo open heart surgery.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecb0c486-e9ba-4dd6-979b-8771a33b3960",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.74,
        "x": 0.128,
        "y": 0.201
      },
      "kind": "paragraph",
      "text": "The future of catheter ablation is bright, and by delivering the fatal blow to minimally invasive ablation and even eating into the concomitant surgical ablation market, it threatens AtriCure's very existence.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe9c5a96-9f93-485c-805a-ba70e208578c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.15,
        "x": 0.128,
        "y": 0.295
      },
      "kind": "title",
      "text": "VI. Conclusion",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7b6df24-471f-4fa8-9fd5-ae031c1328ab",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Storytelling: the closing ask",
      "slug": "closing-ask",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "1cbe6b85-2690-4173-be36-7b56a5fbc3dc",
      "evidence": "This slide is titled 'VI. Conclusion' and contains a call to action regarding the implications for AtriCure.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 31,
      "from": 27,
      "beatId": "b2363734-56f3-46ff-abfb-d7590b7e6299",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The conclusion presents a clear victory for the thesis that AtriCure's growth is set to short-circuit",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 31,
      "from": 25,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3723b781-712f-4a89-8ac6-a6365db45803",
      "evidence": "The document presents a clear warning to investors about the risks of not acting",
      "position": 1,
      "objective": "To highlight the cost of inaction for investors who fail to recognize the threat of emerging technologies to AtriCure's business",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}